# Effectiveness of Anti-IL-5/IL5R Inhibitors

> **NCT06239441** · — · COMPLETED · sponsor: **Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal** · enrollment: 108 (actual)

## Conditions studied

- Severe Asthma

## Interventions

- **DRUG:** IL5/IL5R Antagonists

## Key facts

- **NCT ID:** NCT06239441
- **Lead sponsor:** Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-16
- **Primary completion:** 2023-06-13
- **Final completion:** 2023-11-29
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2024-10-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06239441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06239441, "Effectiveness of Anti-IL-5/IL5R Inhibitors". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT06239441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*